mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.7 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.7 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |